PVP VENTURES LTD.

PVP Ventures Ltd has filed an addendum to its Annual Report concerning the 35th Annual General Meeting. The company is proposing a change of name to "Evervie Health Limited". A compliance certificate from a Practicing Chartered Accountant, as required by SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, has been enclosed. This certificate confirms compliance with Regulation 45(1) and 45(3) regarding the name change, specifically addressing the investment in the new healthcare activity. The AGM is scheduled for September 7, 2026, and all other aspects of the Annual Report for FY 2025-26 remain unchanged.

PVP Ventures Ltd has dispatched letters to shareholders whose email addresses are not registered, providing a weblink to access the Annual Report for FY 2025-26. The 35th Annual General Meeting is scheduled for September 7, 2026, via Video Conferencing. The Annual Report and AGM notice will be sent electronically to shareholders with registered email addresses. The company also reminds shareholders to update KYC details and dematerialize physical securities as per SEBI mandates, with specific forms available on their website and RTA's website. Failure to update KYC for physical holdings may affect dividend payments.

PVP Ventures Ltd has announced its 35th Annual General Meeting (AGM) to be held on September 7, 2026, at 10:00 AM IST via Video Conferencing. The meeting will address the adoption of audited standalone and consolidated financial statements for the fiscal year ending March 31, 2026. A key agenda item is the proposed appointment of M/s. CNGSN & Associates LLP as statutory auditors for a term of five consecutive years, commencing from the conclusion of this AGM until the 40th AGM in 2031. The e-voting period will commence on September 4, 2026, and conclude on September 6, 2026. The record date for determining voting eligibility is August 31, 2026.

PVP Ventures Ltd announced that its Board of Directors accepted the resignations of two directors during a meeting held on August 14, 2026. Mr. Kushal Kumar, a Non-Executive Independent Director, resigned due to personal commitments and international work. Mr. Dileep Badey, an Executive Director, resigned due to personal reasons. The company has filed the necessary disclosures as per SEBI LODR Regulations, 2015.

PVP Ventures Ltd announced that its Board of Directors has accepted the resignations of two directors: Mr. Kushal Kumar, Non-Executive Independent Director, and Mr. Dileep Badey, Executive Director. Both resignations are effective from August 14, 2026. Mr. Kumar cited personal commitments and international engagements as reasons for his departure, while Mr. Badey resigned due to personal reasons. The company has filed the necessary disclosures as per SEBI regulations.

PVP Ventures Ltd announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of Directors approved these results, which were recommended by the Audit Committee. The company also noted the resignation of two directors, Mr. Kushal Kumar and Mr. Dileep Badey. Additionally, the Board approved the notice for the 35th Annual General Meeting scheduled for September 7, 2026, and rectified the designation of Dr. Ellen Jane Feehan to Executive Director and Chief Executive Officer.

PVP Ventures Ltd announced the approval of its Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. The Board also accepted the resignations of Mr. Kushal Kumar (Non-Executive Independent Director) and Mr. Dileep Badey (Executive Director). Additionally, the company approved the notice for its 35th Annual General Meeting scheduled for September 7, 2026, and rectified the designation of Dr. Ellen Jane Feehan to Executive Director and Chief Executive Officer.

PVP Ventures Ltd has announced that its Board of Directors will convene on August 14, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company also informed that the trading window for its directors, designated employees, and their relatives will remain closed from July 1, 2026, until 48 hours after the declaration of these financial results.

PVP Ventures Limited has responded to a BSE query regarding a significant increase in its equity share trading volume. The company stated that it has complied with all SEBI disclosure requirements and has consistently disseminated material information. PVP Ventures confirmed that, to its knowledge, there is no undisclosed material information or event that could explain the recent trading activity. The company attributes the volume surge to normal market operations and investor activity, independent of any company actions. PVP Ventures reiterated its commitment to corporate governance and timely disclosure of material information.

PVP Ventures Ltd has confirmed the payment of interest for its Non-Convertible Debentures (NCDs) as per SEBI regulations. The company made the interest payment on July 21, 2026, for NCDs with ISINs INE362A07054 and INE362A07047. The payment was made to debenture holders listed as beneficial owners on the record date of July 20, 2026. The total interest paid amounts to ₹2,53,33,333 for the first ISIN and ₹1,46,66,667 for the second.